Brevan Howard Capital Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-26,351	Closed	-$79.8K	–	1472
2024 Q4	$79.8K	Buy	26,351 +10,903	+71%	+$33K	﹤0.01%	948
2024 Q3	$56.8K	Sell	15,448 -5,791	-27%	-$21.3K	﹤0.01%	1035
2024 Q2	$86.9K	Buy	21,239 +7,635	+56%	+$31.2K	﹤0.01%	928
2024 Q1	$214K	Buy	+13,604	New	+$214K	﹤0.01%	728